Innovent Biologics, Inc. (FRA:6IB)

Germany · Delayed Price · Currency is EUR

9.75

+0.15 (1.56%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	9.42B	6.21B	4.56B	4.27B	3.84B
Biotechnology Growth	51.82%	36.21%	6.71%	11.08%	266.94%
Total	9.42B	6.21B	4.56B	4.27B	3.84B
Total Growth	51.82%	36.21%	6.71%	11.08%	266.94%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
The People's Republic of China (PRC)	8.98B	5.75B	4.13B	3.97B	2.45B
The People's Republic of China (PRC) Growth	56.14%	39.22%	4.16%	62.16%	133.57%
The United State of Americas	411.59M	442.60M	411.03M	261.64M	1.40B
The United State of Americas Growth	-7.01%	7.68%	57.10%	-81.27%	-
Other	26.88M	10.12M	12.81M	-	-
Other Growth	165.49%	-20.95%	-	-	-
Republic of Indonesia	-	-	-	6.60M	-
Republic of France	-	-	-	33.97M	-
Total	9.42B	6.21B	4.56B	4.27B	3.84B
Total Growth	51.82%	36.21%	6.71%	11.08%	266.94%

Source: S&P Global Market Intelligence.